Eskay Iodine Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 04-07-2024
- Paid Up Capital ₹ 4.00 Cr
as on 04-07-2024
- Company Age 13 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 257.00 Cr
as on 04-07-2024
- Satisfied Charges ₹ 5.00 Cr
as on 04-07-2024
- Revenue 53.44%
(FY 2023)
- Profit 48.05%
(FY 2023)
- Ebitda 46.04%
(FY 2023)
- Net Worth 70.89%
(FY 2023)
- Total Assets 44.72%
(FY 2023)
About Eskay Iodine
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr.
The company currently has active open charges totaling ₹257.00 Cr. The company has closed loans amounting to ₹5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bipin Shah, Ketan Shah, Samir Shah, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100MH2011PTC221911
- Company No.
221911
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 2011
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Eskay Iodine Private Limited offer?
Eskay Iodine Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Construction Chemical, Aluminum Foil Insulation, Roof Heat Insulation Materials, Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream.
Who are the key members and board of directors at Eskay Iodine?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Sharda  | Director | 11-May-2021 | Current |
| Bipin Shah | Director | 19-Oct-2011 | Current |
| Ketan Shah | Director | 13-Sep-2011 | Current |
| Samir Shah | Director | 19-Oct-2011 | Current |
| Lalit Shah | Director | 13-Sep-2011 | Current |
Financial Performance and Corporate Structure Insights of Eskay Iodine.
Eskay Iodine Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 53.44% increase. The company also saw a substantial improvement in profitability, with a 48.05% increase in profit. The company's net worth Soared by an impressive increase of 70.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eskay Iodine?
In 2023, Eskay Iodine had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chaitanya Life Science Private LimitedActive 14 years 6 monthsBipin Shah, Ketan Shah and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 01 Mar 2018 | ₹5.00 Cr | Open |
Hdfc Bank Limited Creation Date: 21 Feb 2013 | ₹50.00 Cr | Open |
Hdfc Bank Limited Creation Date: 15 Jan 2013 | ₹202.00 Cr | Open |
How Many Employees Work at Eskay Iodine?
Eskay Iodine has a workforce of 184 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eskay Iodine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eskay Iodine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
